As of 2025-05-16, the Intrinsic Value of Sunil Healthcare Ltd (537253.BO) is 34.34 INR. This 537253.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 70.71 INR, the upside of Sunil Healthcare Ltd is -51.40%.
The range of the Intrinsic Value is 8.51 - 102.69 INR
Based on its market price of 70.71 INR and our intrinsic valuation, Sunil Healthcare Ltd (537253.BO) is overvalued by 51.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.51 - 102.69 | 34.34 | -51.4% |
| DCF (Growth 10y) | 17.30 - 115.90 | 44.73 | -36.7% |
| DCF (EBITDA 5y) | 61.92 - 97.04 | 78.62 | 11.2% |
| DCF (EBITDA 10y) | 53.75 - 108.71 | 78.08 | 10.4% |
| Fair Value | -39.56 - -39.56 | -39.56 | -155.95% |
| P/E | (35.58) - (38.52) | (37.47) | -153.0% |
| EV/EBITDA | 56.21 - 77.94 | 64.84 | -8.3% |
| EPV | 156.10 - 273.49 | 214.79 | 203.8% |
| DDM - Stable | (8.70) - (27.30) | (18.00) | -125.5% |
| DDM - Multi | 19.80 - 50.95 | 28.83 | -59.2% |
| Market Cap (mil) | 724.78 |
| Beta | 0.78 |
| Outstanding shares (mil) | 10.25 |
| Enterprise Value (mil) | 1,311.07 |
| Market risk premium | 8.31% |
| Cost of Equity | 12.97% |
| Cost of Debt | 14.99% |
| WACC | 11.88% |